(
SEVAMED 2001)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,
Vaccines &
Drugs)
1149.
Hoerauf
A. Volkmann L.
Nissen-Paehle K. Schmetz C. Autenrieth
I. Buttner DW. Fleischer
B.Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of
tetracyclines with chloramphenicol, macrolides and ciprofloxacin.Tropical
Medicine & International Health. 5(4):275-9,
2000 Apr.
1150.
Taylor
MJ. Cross HF. Bilo K. Inflammatory responses induced by the filarial
nematode Brugia malayi are mediated by lipopolysaccharide-like activity from
endosymbiotic Wolbachia bacteria. Journal of Experimental Medicine.
191(8):1429-36, 2000 Apr 17.
1151.
Thanomsub
BW. Chansiri K.
Sarataphan N. Phantana S. Differential diagnosis of human lymphatic
filariasis using PCR-RFLP. Molecular & Cellular Probes. 14(1):41-6, 2000 Feb.
1668. Esterre P. Plichart
C. Huin-Blondey MO. Nguyen L. Role
of streptococcal infection in the
acute pathology of lymphatic filariasis. Parasite.
7(2):91-4, 2000 Jun.
1669. Fontes G.
Rocha EM.
Brito AC.
Fireman FA.
Antunes CM.
The microfilarial
periodicity of
Wuchereria bancrofti
in north-eastern Brazil. Annals
of Tropical Medicine & Parasitology.
94(4):373-9, 2000 Jun.
1670.
Hoffmann W. Petit G. Schulz-Key H. Taylor
D. Bain O. Le Goff L. Litomosoides sigmodontis in mice: reappraisal of
an old model for filarial research.
[ Review ] [35 refs] Parasitology Today.
16(9):387-9, 2000 Sep.
1671. Norman
RA. Chan MS. Srividya A. Pani SP. Ramaiah KD. Vanamail P.Michael E. Das PK.
Bundy DA. EPIFIL : the development
of an
age-structured model
for describing the
transmission dynamics and
control of
lymphatic filariasis.
Epidemiology & Infection. 124(3):529-41,
2000 Jun.
1672.
Plaisier AP. Stolk WA. van Oortmarssen GJ.
Habbema JD.Effectiveness of annual ivermectin treatment for
Wuchereria bancrofti
infection. [ Review ]
[ 19 refs ] Parasitology Today. 16(7):298-302,
2000 Jul.
1673. Ramzy
RM. Helmy H. el-Lethy AS. Kandil
AM. Ahmed ES. Weil GJ. Faris
R. Field evaluation of a rapid-format kit for the diagnosis of bancroftian
filariasis in Egypt. Eastern Mediterranean Health Journal.
5(5):880-7, 2000 Sep.
2157. Esterre P. Plichart C. Sechan Y. Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Tropical Medicine & International Health. 6(3):190-5, 2001 Mar.
2158. Freedman DO. Plier DA. De Almeida AB. De Oliveira AL. Miranda J. Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Medicine & International Health. 6(1):37-41, 2001 Jan.
2159. Gyapong M. Gyapong JO. Owusu-Banahene G. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine & Parasitology. 95(1):77-86, 2001 Jan.
2160. Jain S. Sodhani P. Gupta S. Sakhuja P. Kumar N. Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytologica. 45(2):186-91, 2001 Mar-Apr.
2594. Jain S. Sodhani P. Gupta S. Sakhuja P. Kumar N. Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytologica. 45(2):186-91, 2001 Mar-Apr.
2595. Mohanty MC. Satapathy AK. Sahoo PK. Ravindran B. Human bancroftian filariasis - a role for antibodies to parasite carbohydrates. Clinical & Experimental Immunology. 124(1):54-61, 2001 Apr.
2596. Rathaur S. Sharma S. Singh RN. Henkle K. Selkirk ME. Antibody responses of Wuchereria bancrofti patients to recombinant Brugia pahangi superoxide dismutase. Indian Journal of Experimental Biology. 39(1):35-40, 2001 Jan.